HEADER TRANSFERASE/TRANSFERASE INHIBITOR 11-DEC-16 5WTC TITLE STRUCTURE OF HUMAN PARP1 CATALYTIC DOMAIN BOUND TO A QUINAZOLINE-2, TITLE 2 4(1H,3H)-DIONE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLY [ADP-RIBOSE] POLYMERASE 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, UNP RESIDUES 662-1011; COMPND 5 SYNONYM: PARP-1,ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE 1,ARTD1, COMPND 6 NAD(+) ADP-RIBOSYLTRANSFERASE 1,ADPRT 1,POLY[ADP-RIBOSE] SYNTHASE 1; COMPND 7 EC: 2.4.2.30; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PARP1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, COMPLEX, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR R.CAO,Y.L.WANG,J.ZHOU,N.HUANG,B.L.XU REVDAT 1 25-JAN-17 5WTC 0 JRNL AUTH R.CAO,Y.L.WANG,J.ZHOU,N.HUANG,B.L.XU JRNL TITL STRUCTURE OF HUMAN PARP1 CATALYTIC DOMAIN BOUND TO A JRNL TITL 2 QUINAZOLINE-2,4(1H,3H)-DIONE INHIBITOR JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0123 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 81.92 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 36451 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.225 REMARK 3 R VALUE (WORKING SET) : 0.223 REMARK 3 FREE R VALUE : 0.266 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1910 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2595 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.53 REMARK 3 BIN R VALUE (WORKING SET) : 0.2280 REMARK 3 BIN FREE R VALUE SET COUNT : 147 REMARK 3 BIN FREE R VALUE : 0.2660 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5526 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 66 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.52 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.67000 REMARK 3 B22 (A**2) : 1.44000 REMARK 3 B33 (A**2) : -0.77000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.317 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.234 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.171 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.633 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.910 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.871 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5722 ; 0.019 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 5572 ; 0.003 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7730 ; 1.993 ; 1.993 REMARK 3 BOND ANGLES OTHERS (DEGREES): 12894 ; 1.211 ; 3.003 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 698 ; 7.760 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 246 ;39.706 ;25.203 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1062 ;18.357 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 22 ;19.909 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 860 ; 0.124 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6348 ; 0.009 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 1218 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2804 ; 3.602 ; 2.054 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2803 ; 3.601 ; 2.052 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3498 ; 6.406 ; 3.060 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 3499 ; 6.405 ; 3.063 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2918 ; 2.962 ; 2.339 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2915 ; 2.959 ; 2.338 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 4230 ; 5.288 ; 3.342 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 6170 ; 9.646 ;15.334 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 6171 ; 9.647 ;15.336 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5WTC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 16-DEC-16. REMARK 100 THE DEPOSITION ID IS D_1300002349. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-JUN-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.987 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38426 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 81.930 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.46 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.5M AMMONIUM SULFATE, 100MM TRIS, PH REMARK 280 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.31500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 81.92500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 46.35000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 81.92500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.31500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 46.35000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 724 REMARK 465 SER B 724 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 CG PRO A 915 O MET B 746 4445 1.59 REMARK 500 CA ASP A 914 CA LYS B 748 4445 1.66 REMARK 500 CB PRO A 915 O MET B 746 4445 1.69 REMARK 500 CB ASP A 914 CB LYS B 748 4445 1.70 REMARK 500 CG PRO A 915 C MET B 746 4445 1.74 REMARK 500 O GLY A 913 CA LYS B 748 4445 1.79 REMARK 500 CG PRO A 915 N LYS B 747 4445 1.85 REMARK 500 O GLY A 913 C LYS B 748 4445 1.90 REMARK 500 N ASP A 914 CG LYS B 748 4445 1.99 REMARK 500 N ASP A 914 N LYS B 748 4445 2.01 REMARK 500 CD PRO A 915 N LYS B 748 4445 2.04 REMARK 500 OE1 GLU A 715 NE2 GLN B 705 1455 2.07 REMARK 500 C GLY A 913 CB LYS B 748 4445 2.09 REMARK 500 CA ASP A 914 N LYS B 748 4445 2.12 REMARK 500 CG PRO A 915 CA LYS B 747 4445 2.16 REMARK 500 CD PRO A 915 CA LYS B 747 4445 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ASP A 914 N ASP A 914 CA 0.190 REMARK 500 LYS B 747 N LYS B 747 CA 0.151 REMARK 500 LYS B 748 N LYS B 748 CA 0.150 REMARK 500 LYS B 748 CA LYS B 748 CB 0.213 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 841 NE - CZ - NH1 ANGL. DEV. = 5.1 DEGREES REMARK 500 ARG A 841 NE - CZ - NH2 ANGL. DEV. = -6.5 DEGREES REMARK 500 LYS B 747 N - CA - C ANGL. DEV. = 23.1 DEGREES REMARK 500 LYS B 748 N - CA - CB ANGL. DEV. = 12.9 DEGREES REMARK 500 LYS B 748 CA - CB - CG ANGL. DEV. = 15.9 DEGREES REMARK 500 PRO B 750 C - N - CA ANGL. DEV. = 11.9 DEGREES REMARK 500 ASP B 766 CB - CG - OD1 ANGL. DEV. = 5.8 DEGREES REMARK 500 ARG B 841 NE - CZ - NH1 ANGL. DEV. = 3.9 DEGREES REMARK 500 ARG B 841 NE - CZ - NH2 ANGL. DEV. = -4.5 DEGREES REMARK 500 ARG B 857 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 ASP B 993 CB - CG - OD1 ANGL. DEV. = 7.2 DEGREES REMARK 500 ASP B 993 CB - CG - OD2 ANGL. DEV. = -6.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 662 -15.98 93.39 REMARK 500 SER A 663 123.07 81.37 REMARK 500 GLU A 690 14.73 82.02 REMARK 500 LYS A 747 -127.44 53.76 REMARK 500 LYS A 748 98.16 71.16 REMARK 500 ASP A 914 85.92 -171.98 REMARK 500 ASP A 981 75.21 -117.83 REMARK 500 LYS B 662 -10.26 71.06 REMARK 500 SER B 663 129.66 71.74 REMARK 500 SER B 721 34.47 -72.35 REMARK 500 GLN B 722 94.23 167.05 REMARK 500 ASP B 726 6.52 -61.15 REMARK 500 LYS B 747 -109.55 75.92 REMARK 500 LYS B 748 64.28 19.02 REMARK 500 PRO B 750 103.49 -26.93 REMARK 500 LEU B 752 65.53 -104.49 REMARK 500 ALA B 755 -67.88 -26.50 REMARK 500 ASP B 957 107.94 -32.41 REMARK 500 ASN B 980 -72.20 -66.87 REMARK 500 GLN B 996 4.87 -68.86 REMARK 500 LYS B1000 -52.09 -121.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 MET A 746 LYS A 747 132.25 REMARK 500 LYS A 747 LYS A 748 -134.71 REMARK 500 ASP B 743 PHE B 744 140.07 REMARK 500 PHE B 744 GLY B 745 144.73 REMARK 500 MET B 746 LYS B 747 127.51 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 7UL A 1101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 7UL B 1101 DBREF 5WTC A 662 1011 UNP P09874 PARP1_HUMAN 662 1011 DBREF 5WTC B 662 1011 UNP P09874 PARP1_HUMAN 662 1011 SEQADV 5WTC HIS A 660 UNP P09874 EXPRESSION TAG SEQADV 5WTC MET A 661 UNP P09874 EXPRESSION TAG SEQADV 5WTC ALA A 762 UNP P09874 VAL 762 ENGINEERED MUTATION SEQADV 5WTC HIS B 660 UNP P09874 EXPRESSION TAG SEQADV 5WTC MET B 661 UNP P09874 EXPRESSION TAG SEQADV 5WTC ALA B 762 UNP P09874 VAL 762 ENGINEERED MUTATION SEQRES 1 A 352 HIS MET LYS SER LYS LEU PRO LYS PRO VAL GLN ASP LEU SEQRES 2 A 352 ILE LYS MET ILE PHE ASP VAL GLU SER MET LYS LYS ALA SEQRES 3 A 352 MET VAL GLU TYR GLU ILE ASP LEU GLN LYS MET PRO LEU SEQRES 4 A 352 GLY LYS LEU SER LYS ARG GLN ILE GLN ALA ALA TYR SER SEQRES 5 A 352 ILE LEU SER GLU VAL GLN GLN ALA VAL SER GLN GLY SER SEQRES 6 A 352 SER ASP SER GLN ILE LEU ASP LEU SER ASN ARG PHE TYR SEQRES 7 A 352 THR LEU ILE PRO HIS ASP PHE GLY MET LYS LYS PRO PRO SEQRES 8 A 352 LEU LEU ASN ASN ALA ASP SER VAL GLN ALA LYS ALA GLU SEQRES 9 A 352 MET LEU ASP ASN LEU LEU ASP ILE GLU VAL ALA TYR SER SEQRES 10 A 352 LEU LEU ARG GLY GLY SER ASP ASP SER SER LYS ASP PRO SEQRES 11 A 352 ILE ASP VAL ASN TYR GLU LYS LEU LYS THR ASP ILE LYS SEQRES 12 A 352 VAL VAL ASP ARG ASP SER GLU GLU ALA GLU ILE ILE ARG SEQRES 13 A 352 LYS TYR VAL LYS ASN THR HIS ALA THR THR HIS ASN ALA SEQRES 14 A 352 TYR ASP LEU GLU VAL ILE ASP ILE PHE LYS ILE GLU ARG SEQRES 15 A 352 GLU GLY GLU CYS GLN ARG TYR LYS PRO PHE LYS GLN LEU SEQRES 16 A 352 HIS ASN ARG ARG LEU LEU TRP HIS GLY SER ARG THR THR SEQRES 17 A 352 ASN PHE ALA GLY ILE LEU SER GLN GLY LEU ARG ILE ALA SEQRES 18 A 352 PRO PRO GLU ALA PRO VAL THR GLY TYR MET PHE GLY LYS SEQRES 19 A 352 GLY ILE TYR PHE ALA ASP MET VAL SER LYS SER ALA ASN SEQRES 20 A 352 TYR CYS HIS THR SER GLN GLY ASP PRO ILE GLY LEU ILE SEQRES 21 A 352 LEU LEU GLY GLU VAL ALA LEU GLY ASN MET TYR GLU LEU SEQRES 22 A 352 LYS HIS ALA SER HIS ILE SER LYS LEU PRO LYS GLY LYS SEQRES 23 A 352 HIS SER VAL LYS GLY LEU GLY LYS THR THR PRO ASP PRO SEQRES 24 A 352 SER ALA ASN ILE SER LEU ASP GLY VAL ASP VAL PRO LEU SEQRES 25 A 352 GLY THR GLY ILE SER SER GLY VAL ASN ASP THR SER LEU SEQRES 26 A 352 LEU TYR ASN GLU TYR ILE VAL TYR ASP ILE ALA GLN VAL SEQRES 27 A 352 ASN LEU LYS TYR LEU LEU LYS LEU LYS PHE ASN PHE LYS SEQRES 28 A 352 THR SEQRES 1 B 352 HIS MET LYS SER LYS LEU PRO LYS PRO VAL GLN ASP LEU SEQRES 2 B 352 ILE LYS MET ILE PHE ASP VAL GLU SER MET LYS LYS ALA SEQRES 3 B 352 MET VAL GLU TYR GLU ILE ASP LEU GLN LYS MET PRO LEU SEQRES 4 B 352 GLY LYS LEU SER LYS ARG GLN ILE GLN ALA ALA TYR SER SEQRES 5 B 352 ILE LEU SER GLU VAL GLN GLN ALA VAL SER GLN GLY SER SEQRES 6 B 352 SER ASP SER GLN ILE LEU ASP LEU SER ASN ARG PHE TYR SEQRES 7 B 352 THR LEU ILE PRO HIS ASP PHE GLY MET LYS LYS PRO PRO SEQRES 8 B 352 LEU LEU ASN ASN ALA ASP SER VAL GLN ALA LYS ALA GLU SEQRES 9 B 352 MET LEU ASP ASN LEU LEU ASP ILE GLU VAL ALA TYR SER SEQRES 10 B 352 LEU LEU ARG GLY GLY SER ASP ASP SER SER LYS ASP PRO SEQRES 11 B 352 ILE ASP VAL ASN TYR GLU LYS LEU LYS THR ASP ILE LYS SEQRES 12 B 352 VAL VAL ASP ARG ASP SER GLU GLU ALA GLU ILE ILE ARG SEQRES 13 B 352 LYS TYR VAL LYS ASN THR HIS ALA THR THR HIS ASN ALA SEQRES 14 B 352 TYR ASP LEU GLU VAL ILE ASP ILE PHE LYS ILE GLU ARG SEQRES 15 B 352 GLU GLY GLU CYS GLN ARG TYR LYS PRO PHE LYS GLN LEU SEQRES 16 B 352 HIS ASN ARG ARG LEU LEU TRP HIS GLY SER ARG THR THR SEQRES 17 B 352 ASN PHE ALA GLY ILE LEU SER GLN GLY LEU ARG ILE ALA SEQRES 18 B 352 PRO PRO GLU ALA PRO VAL THR GLY TYR MET PHE GLY LYS SEQRES 19 B 352 GLY ILE TYR PHE ALA ASP MET VAL SER LYS SER ALA ASN SEQRES 20 B 352 TYR CYS HIS THR SER GLN GLY ASP PRO ILE GLY LEU ILE SEQRES 21 B 352 LEU LEU GLY GLU VAL ALA LEU GLY ASN MET TYR GLU LEU SEQRES 22 B 352 LYS HIS ALA SER HIS ILE SER LYS LEU PRO LYS GLY LYS SEQRES 23 B 352 HIS SER VAL LYS GLY LEU GLY LYS THR THR PRO ASP PRO SEQRES 24 B 352 SER ALA ASN ILE SER LEU ASP GLY VAL ASP VAL PRO LEU SEQRES 25 B 352 GLY THR GLY ILE SER SER GLY VAL ASN ASP THR SER LEU SEQRES 26 B 352 LEU TYR ASN GLU TYR ILE VAL TYR ASP ILE ALA GLN VAL SEQRES 27 B 352 ASN LEU LYS TYR LEU LEU LYS LEU LYS PHE ASN PHE LYS SEQRES 28 B 352 THR HET 7UL A1101 33 HET 7UL B1101 33 HETNAM 7UL 1-[[4-FLUORANYL-3-[4-[2,2,2-TRIS(FLUORANYL) HETNAM 2 7UL ETHYL]PIPERAZIN-1-YL]CARBONYL- HETNAM 3 7UL PHENYL]METHYL]QUINAZOLINE-2,4-DIONE FORMUL 3 7UL 2(C22 H20 F4 N4 O3) HELIX 1 AA1 PRO A 666 PHE A 677 1 12 HELIX 2 AA2 ASP A 678 TYR A 689 1 12 HELIX 3 AA3 PRO A 697 LEU A 701 5 5 HELIX 4 AA4 SER A 702 GLN A 722 1 21 HELIX 5 AA5 ASP A 726 ILE A 740 1 15 HELIX 6 AA6 ASN A 754 GLY A 780 1 27 HELIX 7 AA7 ASP A 788 LEU A 797 1 10 HELIX 8 AA8 SER A 808 THR A 821 1 14 HELIX 9 AA9 ALA A 823 ASN A 827 5 5 HELIX 10 AB1 GLY A 843 TYR A 848 1 6 HELIX 11 AB2 LYS A 849 LYS A 852 5 4 HELIX 12 AB3 ARG A 865 THR A 867 5 3 HELIX 13 AB4 ASN A 868 GLY A 876 1 9 HELIX 14 AB5 PRO A 885 TYR A 889 5 5 HELIX 15 AB6 MET A 900 TYR A 907 1 8 HELIX 16 AB7 PRO A 958 ASN A 961 5 4 HELIX 17 AB8 ASP A 993 ALA A 995 5 3 HELIX 18 AB9 PRO B 666 PHE B 677 1 12 HELIX 19 AC1 ASP B 678 TYR B 689 1 12 HELIX 20 AC2 PRO B 697 LEU B 701 5 5 HELIX 21 AC3 SER B 702 SER B 721 1 20 HELIX 22 AC4 ASP B 726 ILE B 740 1 15 HELIX 23 AC5 ASN B 754 GLY B 780 1 27 HELIX 24 AC6 ASP B 788 LEU B 797 1 10 HELIX 25 AC7 SER B 808 THR B 821 1 14 HELIX 26 AC8 GLY B 843 LYS B 849 1 7 HELIX 27 AC9 PRO B 850 LYS B 852 5 3 HELIX 28 AD1 ARG B 865 THR B 867 5 3 HELIX 29 AD2 ASN B 868 GLY B 876 1 9 HELIX 30 AD3 PRO B 885 TYR B 889 5 5 HELIX 31 AD4 MET B 900 TYR B 907 1 8 HELIX 32 AD5 PRO B 958 ASN B 961 5 4 HELIX 33 AD6 ASP B 993 ALA B 995 5 3 SHEET 1 AA1 5 THR A 799 VAL A 803 0 SHEET 2 AA1 5 TYR A 829 ARG A 841 -1 O GLU A 840 N ASP A 800 SHEET 3 AA1 5 VAL A 997 PHE A1009 -1 O ASN A1008 N ASP A 830 SHEET 4 AA1 5 ILE A 916 ALA A 925 -1 N ILE A 919 O LEU A1003 SHEET 5 AA1 5 ARG A 857 SER A 864 -1 N HIS A 862 O LEU A 920 SHEET 1 AA2 4 ILE A 895 PHE A 897 0 SHEET 2 AA2 4 GLU A 988 VAL A 991 -1 O VAL A 991 N ILE A 895 SHEET 3 AA2 4 SER A 947 GLY A 950 -1 N GLY A 950 O GLU A 988 SHEET 4 AA2 4 MET A 929 LEU A 932 1 N LEU A 932 O LYS A 949 SHEET 1 AA3 3 GLY A 974 SER A 976 0 SHEET 2 AA3 3 GLY A 952 PRO A 956 -1 N THR A 955 O ILE A 975 SHEET 3 AA3 3 LEU A 984 TYR A 986 1 O LEU A 985 N THR A 954 SHEET 1 AA4 2 ILE A 962 LEU A 964 0 SHEET 2 AA4 2 VAL A 967 VAL A 969 -1 O VAL A 969 N ILE A 962 SHEET 1 AA5 5 THR B 799 VAL B 803 0 SHEET 2 AA5 5 TYR B 829 ARG B 841 -1 O LYS B 838 N LYS B 802 SHEET 3 AA5 5 VAL B 997 PHE B1009 -1 O ASN B1008 N ASP B 830 SHEET 4 AA5 5 ILE B 916 ALA B 925 -1 N GLY B 917 O LEU B1005 SHEET 5 AA5 5 ARG B 857 SER B 864 -1 N LEU B 860 O GLY B 922 SHEET 1 AA6 4 ILE B 895 PHE B 897 0 SHEET 2 AA6 4 GLU B 988 VAL B 991 -1 O TYR B 989 N PHE B 897 SHEET 3 AA6 4 SER B 947 GLY B 950 -1 N VAL B 948 O ILE B 990 SHEET 4 AA6 4 MET B 929 LEU B 932 1 N LEU B 932 O LYS B 949 SHEET 1 AA7 2 THR B 954 PRO B 956 0 SHEET 2 AA7 2 GLY B 974 SER B 976 -1 O ILE B 975 N THR B 955 SHEET 1 AA8 2 ILE B 962 LEU B 964 0 SHEET 2 AA8 2 VAL B 967 VAL B 969 -1 O VAL B 969 N ILE B 962 LINK C GLY A 913 CA LYS B 748 1555 4445 1.54 LINK N ASP A 914 CA LYS B 748 1555 4445 1.30 LINK N ASP A 914 CB LYS B 748 1555 4445 1.41 LINK CA ASP A 914 CB LYS B 748 1555 4445 1.44 LINK CD PRO A 915 C LYS B 747 1555 4445 1.65 SITE 1 AC1 15 ASP A 766 LEU A 769 HIS A 862 GLY A 863 SITE 2 AC1 15 ARG A 878 ILE A 879 ALA A 880 TYR A 889 SITE 3 AC1 15 GLY A 894 ILE A 895 TYR A 896 PHE A 897 SITE 4 AC1 15 SER A 904 TYR A 907 GLU A 988 SITE 1 AC2 14 ASP B 766 HIS B 862 GLY B 863 ARG B 878 SITE 2 AC2 14 ILE B 879 ALA B 880 TYR B 889 GLY B 894 SITE 3 AC2 14 ILE B 895 TYR B 896 PHE B 897 SER B 904 SITE 4 AC2 14 TYR B 907 GLU B 988 CRYST1 48.630 92.700 163.850 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020564 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010787 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006103 0.00000